Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
B1101 thrombolysis in acute ischemic stroke (phase II)
CTR20160953Phase 2Completed
- Sponsor
- Shanghai Tasly Biopharmaceutical
- Start
- Dec 2016
- Modality
- Metabolic Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of recombinant human prourokinase in ischemic stroke, sponsored by Shanghai Tasly Biopharmaceutical. Started Dec 2016; status: completed.
02
Drugs
recombinant human prourokinase
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on CTR20160953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160953.